RxDoctor Payments Data

Emily Reynolds, APRN

Family · Evansville, INNPI 1962095745

Payments from drug & device makers

$1,849in general payments, 2019–2025

Across 121 payments — averaging $15.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$417
  • Otsuka America Pharmaceutical, Inc.$316
  • Alkermes, Inc.$204
  • Lundbeck LLC$158
  • Vanda Pharmaceuticals Inc.$149
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$105
  • plus $499 from 13 others

What the payments were for

  • Food & beverage$1,849100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,849 in reported general payments places this provider in the 75th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$15,759
Medicare patients
25
Services billed
332

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron Hcl41$87,928
OzempicSemaglutide23$20,382
VraylarCariprazine Hcl12$17,097
Desvenlafaxine Succinate ErDesvenlafaxine Succinate33$5,749
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl54$3,653
Pantoprazole Sodium30$3,523
Celecoxib26$2,717
Solifenacin Succinate11$2,672
Humalog Kwikpen U-100Insulin Lispro12$1,871
Oxaprozin15$884
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen41$500
Tizanidine Hcl12$426
Ondansetron OdtOndansetron16$420
Propranolol Hcl ErPropranolol Hcl13$380
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine14$325

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$36$20,38223 claims
AbbVieVraylar$417$17,09712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,392 family providers in Indiana.

Other family in Evansville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →